Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1995-4-7
pubmed:abstractText
Despite improvement in chemotherapy and supportive care over the past two decades, overall survival for patients with acute myelogenous leukemia (AML) remains poor; only 25% to 30% of individuals with this disorder will be cured. In 1987, we initiated a prospective multiinstitution study designed to improve long-term survival in adults with AML.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
560-9
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:7884416-Adolescent, pubmed-meshheading:7884416-Adult, pubmed-meshheading:7884416-Analysis of Variance, pubmed-meshheading:7884416-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:7884416-Bone Marrow Transplantation, pubmed-meshheading:7884416-Cytarabine, pubmed-meshheading:7884416-Daunorubicin, pubmed-meshheading:7884416-Disease-Free Survival, pubmed-meshheading:7884416-Etoposide, pubmed-meshheading:7884416-Female, pubmed-meshheading:7884416-Humans, pubmed-meshheading:7884416-Leukemia, Myeloid, Acute, pubmed-meshheading:7884416-Male, pubmed-meshheading:7884416-Middle Aged, pubmed-meshheading:7884416-Prognosis, pubmed-meshheading:7884416-Prospective Studies, pubmed-meshheading:7884416-Regression Analysis, pubmed-meshheading:7884416-Remission Induction, pubmed-meshheading:7884416-Survival Rate, pubmed-meshheading:7884416-Transplantation, Autologous, pubmed-meshheading:7884416-Transplantation, Homologous, pubmed-meshheading:7884416-United States
pubmed:year
1995
pubmed:articleTitle
Improved survival for patients with acute myelogenous leukemia.
pubmed:affiliation
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't, Multicenter Study